Hyperphosphatemia
📧 Sign up to get email alerts when something new happens for Hyperphosphatemia.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-03-24EMA Authorised: Velphoro (sucroferric oxyhydroxide) — Vifor Fresenius Medical Care Renal Pharma France
The EMA authorized Velphoro (sucroferric oxyhydroxide) for the treatment of hyperphosphatemia in patients with chronic kidney disease on ren…
-
EMA approval · 2025-11-06EMA Authorised: Xoanacyl (ferric citrate coordination complex) — Averoa
EMA authorised Xoanacyl, a ferric citrate coordination complex, for the treatment of iron deficiency and to manage hyperphosphatemia in chro…
-
FDA approval · 2025-10-27FDA Approved: SEVELAMER CARBONATE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved sevelamer carbonate (generic) from Zydus Pharmaceuticals USA Inc. as an original application. The approval covers treatment of …
-
FDA approval · 2025-03-10FDA Approved: SEVELAMER CARBONATE — Supplemental Application (DR. REDDY'S LABORATORIES LIMITED)
FDA approves a supplemental application for sevelamer carbonate filed by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2025-02-03FDA Approved: SEVELAMER HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves the original application for sevelamer hydrochloride (generic) by Zydus Pharmaceuticals USA Inc. for the treatment of hyperphos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-31FDA Approved: LANTHANUM CARBONATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for Lanthanum carbonate from Cipla USA Inc., approving an update to the product's labeling for the g…
-
EMA approval · 2025-01-22EMA Authorised: Renagel (sevelamer) — Sanofi Winthrop Industrie
The EMA authorised Renagel (sevelamer) for hyperphosphatemia in patients with chronic kidney disease on dialysis, with Sanofi Winthrop Indus…
-
EMA approval · 2025-01-08EMA Authorised: Renvela (sevelamer carbonate) — Sanofi Winthrop Industrie
The EMA authorized Renvela (sevelamer carbonate) for the treatment of hyperphosphatemia in patients on renal dialysis, under Sanofi Winthrop…
-
EMA approval · 2024-12-18EMA Authorised: Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva) (sevelamer carbonate) — Sanofi Winthrop Industrie
EMA has authorised Sevelamer carbonate Winthrop for treating hyperphosphatemia in patients on renal dialysis (formerly Zentiva), with Sanofi…
-
FDA approval · 2024-12-11FDA Approved: LANTHANUM CARBONATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for lanthanum carbonate from Teva Pharmaceuticals USA, Inc. This action is a supplemental approval f…
-
FDA approval · 2024-10-24FDA Approved: SEVELAMER CARBONATE — Original Application (AiPing Pharmaceutical, Inc.)
FDA approved AiPing Pharmaceutical's sevelamer carbonate through an original application as a phosphate binder to control serum phosphate in…
-
FDA approval · 2024-08-29FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Fosrenol (lanthanum carbonate) filed by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2024-08-29FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Fosrenol (lanthanum carbonate) from Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2024-07-01FDA Approved: VELPHORO — Supplemental Application (Fresenius Medical Care Renal Therapies Group, LLC)
The FDA approved a supplemental application for Velphoro (sucroferric oxyhydroxide) submitted by Fresenius Medical Care Renal Therapies Grou…
-
FDA approval · 2024-05-09FDA Approved: SEVELAMER CARBONATE — Original Application (Strides Pharma Science Limited)
FDA approved the original application for Sevelamer carbonate from Strides Pharma Science Limited. The product is a phosphate binder used to…
-
FDA approval · 2024-04-30FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for sevelamer carbonate filed by Aurobindo Pharma Limited, enabling a supplemental approval for …
-
FDA approval · 2024-04-25FDA Approved: SEVELAMER CARBONATE — Original Application (NorthStar RxLLC)
FDA approved NorthStar RxLLC's generic sevelamer carbonate (ANDA 207291) for the treatment of hyperphosphatemia in adults with chronic kidne…
-
FDA approval · 2024-04-10FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA granted supplemental approval for Sevelamer Carbonate from Macleods Pharmaceuticals Limited under an ANDA.
-
FDA approval · 2024-01-19FDA Approved: FERRIC CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Ferric Citrate by Mylan Pharmaceuticals Inc., marking regulatory authorization for an updated su…
-
FDA approval · 2023-12-22FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for sevelamer hydrochloride submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2023-12-12FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Fosrenol (lanthanum carbonate) from Takeda Pharmaceuticals America, Inc., resulting in changes t…
-
FDA approval · 2023-12-06FDA Approved: LANTHANUM CARBONATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for lanthanum carbonate (Cipla USA Inc.). This action updates the product's regulatory approval stat…
-
FDA approval · 2023-10-17FDA Approved: XPHOZAH 10 MG — Original Application (Ardelyx, Inc.)
FDA approved XPHOZAH (tenapanor) from Ardelyx in its original NDA for the treatment of hyperphosphatemia in adults with chronic kidney disea…
-
FDA approval · 2023-09-08FDA Approved: SEVELAMER CARBONATE — Original Application (Strides Pharma Science Limited)
FDA approved the original abbreviated new drug application for sevelamer carbonate from Strides Pharma Science Limited, a generic phosphate …
-
FDA approval · 2023-07-11FDA Approved: SEVELAMER HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved an original ANDA for sevelamer hydrochloride by Aurobindo Pharma Limited, establishing a generic version of the phosphate binde…